Trade HOOKIPA Pharma Inc. - HOOK CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0379 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023374% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001151% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 0.7376 |
| Open | 0.7874 |
| 1-Year Change | 11.66% |
| Day's Range | 0.7076 - 0.7874 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 23, 2025 | 0.7625 | -0.0249 | -3.16% | 0.7874 | 0.7874 | 0.7076 |
| Apr 22, 2025 | 0.7376 | -0.0200 | -2.64% | 0.7576 | 0.7596 | 0.7076 |
| Apr 21, 2025 | 0.7376 | -0.0020 | -0.27% | 0.7396 | 0.7776 | 0.7076 |
| Apr 17, 2025 | 0.7609 | 0.0133 | 1.78% | 0.7476 | 0.7609 | 0.7145 |
| Apr 16, 2025 | 0.7580 | -0.0296 | -3.76% | 0.7876 | 0.8171 | 0.7576 |
| Apr 15, 2025 | 0.7776 | 0.0300 | 4.01% | 0.7476 | 0.7777 | 0.7476 |
| Apr 14, 2025 | 0.7480 | 0.0104 | 1.41% | 0.7376 | 0.7480 | 0.7276 |
| Apr 11, 2025 | 0.7376 | -0.0500 | -6.35% | 0.7876 | 0.7876 | 0.7076 |
| Apr 10, 2025 | 0.7276 | -0.0200 | -2.68% | 0.7476 | 0.7976 | 0.7276 |
| Apr 9, 2025 | 0.7476 | 0.0000 | 0.00% | 0.7476 | 0.7755 | 0.7076 |
| Apr 8, 2025 | 0.7396 | -0.0480 | -6.09% | 0.7876 | 0.7876 | 0.7161 |
| Apr 7, 2025 | 0.7776 | -0.0401 | -4.90% | 0.8177 | 0.8178 | 0.7381 |
| Apr 4, 2025 | 0.8115 | -0.0111 | -1.35% | 0.8226 | 0.8477 | 0.8115 |
| Apr 3, 2025 | 0.8375 | -0.0513 | -5.77% | 0.8888 | 0.9276 | 0.7976 |
| Apr 2, 2025 | 0.9041 | -0.0735 | -7.52% | 0.9776 | 0.9781 | 0.8600 |
| Apr 1, 2025 | 0.9876 | -0.0500 | -4.82% | 1.0376 | 1.0476 | 0.9676 |
| Mar 31, 2025 | 1.0476 | -0.1000 | -8.71% | 1.1476 | 1.1476 | 1.0376 |
| Mar 28, 2025 | 1.1676 | 0.0100 | 0.86% | 1.1576 | 1.2176 | 1.1476 |
| Mar 27, 2025 | 1.1576 | -0.0400 | -3.34% | 1.1976 | 1.2076 | 1.1576 |
| Mar 26, 2025 | 1.2076 | 0.0200 | 1.68% | 1.1876 | 1.2176 | 1.1876 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
HOOKIPA Pharma Inc. Company profile
About Hookipa Pharma Inc
HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company. The Company develops immunotherapeutics based on its arenavirus platform that are designed to target and amplify a T cell and immune response to disease. The Company's infectious and oncology product candidates HB-101, HB-201, HB-202 and HB-300. The infectious disease product candidate, HB-101, is in a randomized, double-blinded Phase II clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates, HB-201 and HB-202, are in development for the treatment of human papillomavirus-positive cancers. The Company is developing its self-antigen project in this area, HB-300, as a replicating technology-based product candidate in metastatic, hormone-resistant prostate cancer.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Hookipa Pharma Inc revenues increased 1% to $14.6M. Net loss increased 72% to $54.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and development - Balancing val increase of 60% to $58M (expense), Other income and expenses, net decrease from $1.6M (income) to $1.3M (expense).
| Industry: | Pharmaceuticals (NEC) |
The Empire State Building
350 Fifth Avenue, Room/Suite 7240
NEW YORK
NEW YORK 10118
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com